Literature DB >> 18318579

Application of immunohistochemistry to thyroid neoplasms.

Sandra Fischer1, Sylvia L Asa.   

Abstract

CONTEXT: Thyroid lesions with nodular architecture and follicular pattern of growth often pose difficulties in accurate diagnosis during the assessment of cytologic and histologic specimens. The diagnosis of follicular neoplasm on cytology or of follicular tumor of uncertain malignant potential on histology is likely to cause confusion among clinicians and delay effective management of these lesions. Occasionally, thyroid tumors represent unusual or metastatic lesions and their accurate diagnosis requires immunohistochemical confirmation.
OBJECTIVE: To review the literature on the applications of immunohistochemistry in the differential diagnosis of thyroid tumors. DATA SOURCES: Relevant articles indexed in PubMed (National Library of Medicine) between 1976 and 2006.
CONCLUSIONS: Our review supports the use of ancillary techniques involving a panel of antibodies suitable for immunohistochemistry and molecular analysis in the assessment of thyroid nodules. These tools can improve diagnostic accuracy when combined with standard morphologic criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18318579     DOI: 10.5858/2008-132-359-AOITTN

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  40 in total

Review 1.  Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.

Authors:  Raziyeh Abooshahab; Morteza Gholami; Maryam Sanoie; Fereidoun Azizi; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-04-01       Impact factor: 3.633

2.  Medullary thyroid carcinoma: a 25-year perspective.

Authors:  Xavier Matias-Guiu; Ronald De Lellis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 3.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

4.  Use of vemurafenib in anaplastic thyroid carcinoma: a case report.

Authors:  Kristen A Marten; Vinay K Gudena
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

5.  Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

Authors:  Tijana M Isic Dencic; Svetlana B Savin; Sonja A Selemetjev; Svetlana D Paskas; Vladan R Zivaljevic; Vesna D Bozic; Dubravka S Cvejic
Journal:  Pathol Oncol Res       Date:  2015-01-11       Impact factor: 3.201

6.  The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.

Authors:  Xueyang Yang; Yifang Hu; He Shi; Chengzhou Zhang; Zhixiao Wang; Xiaoyun Liu; Huanhuan Chen; Lijuan Zhang; Dai Cui
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-27       Impact factor: 2.503

7.  Hashimotos Thyroiditis with Coexistent Papillary Carcinoma and Non-hodgkin Lymphoma-thyroid.

Authors:  Ks Jayaprakash; Hl Kishanprasad; P Hegde; R Chandrika
Journal:  Ann Med Health Sci Res       Date:  2014-03

8.  Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms.

Authors:  Dalia Rifaat Al-Sharaky; Sheren Fouad Younes
Journal:  J Clin Diagn Res       Date:  2016-03-01

9.  Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Elpida Poulaki; Ioanna Delladetsima; Constantinos Troungos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

10.  Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Ioanna Delladetsima; Ioanna Giannopoulou; Efstratios Patsouris; Stamatios Theocharis
Journal:  Tumour Biol       Date:  2013-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.